Skip to main content

Secondary Prevention After Non-atherosclerotic Cerebral Vasculopathies

  • Chapter
Ischemic Stroke Therapeutics

Abstract

Uncommon causes of stroke represent up to 5 % of all ischemic strokes. Non-atherosclerotic vasculopathies (NAVs) account for a minority of strokes and are of particular importance in children and young adults, accounting for 14–25 % of strokes in patients under the age of 50. NAVs comprise a great variety of diseases with various underlying mechanisms including immunological, infective, collagen vascular, and hematological conditions. Increased availability of multimodal brain imaging and improved quality of noninvasive angiographic imaging has allowed more accurate and timely diagnoses, as well as better differentiation among such vasculopathies, resulting in appropriate management and enhanced outcomes. Arterial dissection, both traumatic and spontaneous, is the most common of the NAVs. Dissection is often interlinked with other arteriopathies including fibromuscular dysplasia and collagen vascular disorders. Other NAVs are being increasingly recognized, including reversible cerebral vasoconstriction syndrome, unilateral intracranial arteriopathy of childhood, moyamoya disease, post-radiation vasculopathies, and cerebral vasculitides. Mechanisms of stroke in NAVs vary from traumatic vessel injury to inflammation and infection, often in the setting of an underlying genetic predisposition. This chapter reviews the clinical manifestations, diagnosis, and management of the most common NAVs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ABRA:

Amyloid β-related angiitis

ACA:

Anterior cerebral arteries

CNS:

Central nervous system

CAA:

Cerebral amyloid angiopathy

CSF:

Cerebrospinal fluid

CCAD:

Cervicocephalic arterial dissection

FMD:

Fibromuscular dysplasia

GCA:

Giant cell arteritis

ICA:

Internal carotid artery

MCA:

Middle cerebral artery

NAV:

Non-atherosclerotic vasculopathy

PRES:

Posterior reversible ischemic encephalopathy syndrome

PACNS:

Primary angiitis of the CNS

RCVS:

Reversible cerebral vasoconstriction syndrome

SAH:

Subarachnoid hemorrhage

References

  1. Biller J, Adams Jr HP, Bruno A, Love BB, Marsh III EE. Mortality in acute cerebral infarction in young adults – a ten-year experience. Angiology. 1991;42(3):224–30.

    Article  CAS  PubMed  Google Scholar 

  2. Dafer RM, Biller J. Non-atherosclerotic cerebral vasculopathies. In: Gilman S, editor. Neurobiology of disease. San Diego, CA: Elsevier; 2006. p. 255–64.

    Google Scholar 

  3. Dafer RM, Biller J. Non-atherosclerotic vasculopathies. In: Biller J, editor. Stroke in Children and young adults. 2nd ed. Philadelphia, PA: Saunders Elsevier; 2009. p. 115–34.

    Chapter  Google Scholar 

  4. Saver JL, Easton JDH. Dissection and trauma of cervicocerebral arteries. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, editors. Stroke, pathophysiology, diagnosis and management. 2nd ed. New York, NY: Churchill Livingstone Inc; 1992. p. 671–88.

    Google Scholar 

  5. Mokri B. Cervicocephalic arterial dissections. In: Bogousslavsky J, Caplan LR, editors. Uncommon causes of stroke. Cambridge: Cambridge University Press; 2001. p. 211–29.

    Google Scholar 

  6. Schievink WI, Mokri B, Piepgras DG. Spontaneous dissections of cervicocephalic arteries in childhood and adolescence. Neurology. 1994;44(9):1607–12.

    Article  CAS  PubMed  Google Scholar 

  7. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med. 2001;344(12):898–906.

    Article  CAS  PubMed  Google Scholar 

  8. Fisher CM, Ojemann RG, Roberson GH. Spontaneous dissection of cervico-cerebral arteries. Can J Neurol Sci. 1978;5(1):9–19.

    CAS  PubMed  Google Scholar 

  9. Baumgartner RW, Lienhardt B, Mosso M, Gandjour J, Michael N, Georgiadis D. Spontaneous and endothelial-independent vasodilation are impaired in patients with spontaneous carotid dissection: a case-control study. Stroke. 2007;38(2):405–6.

    Article  PubMed  Google Scholar 

  10. Lucas C, Moulin T, Deplanque D, Tatu L, Chavot D. Stroke patterns of internal carotid artery dissection in 40 patients. Stroke. 1998;29(12):2646–8.

    Article  CAS  PubMed  Google Scholar 

  11. Treiman GS, Treiman RL, Foran RF, Levin PM, Cohen JL, Wagner WH, et al. Spontaneous dissection of the internal carotid artery: a nineteen-year clinical experience. J Vasc Surg. 1996;24(4):597–605.

    Article  CAS  PubMed  Google Scholar 

  12. Caso V, Paciaroni M, Bogousslavsky J. Environmental factors and cervical artery dissection. Front Neurol Neurosci. 2005;20:44–53.

    Article  PubMed  Google Scholar 

  13. Grau AJ, Brandt T, Buggle F, Orberk E, Mytilineos J, Werle E, et al. Association of cervical artery dissection with recent infection. Arch Neurol. 1999;56(7):851–6.

    Article  CAS  PubMed  Google Scholar 

  14. Schievink WI, Atkinson JL, Bartleson JD, Whisnant JP. Traumatic internal carotid artery dissections caused by blunt softball injuries. Am J Emerg Med. 1998;16(2):179–82.

    Article  CAS  PubMed  Google Scholar 

  15. Smith WS, Johnston SC, Skalabrin EJ, Weaver M, Azari P, Albers GW, et al. Spinal manipulative therapy is an independent risk factor for vertebral artery dissection. Neurology. 2003;60(9):1424–8.

    Article  CAS  PubMed  Google Scholar 

  16. Mourad JJ, Girerd X, Safar M. Carotid-artery dissection after a prolonged telephone call. N Engl J Med. 1997;336(7):516.

    Article  CAS  PubMed  Google Scholar 

  17. Schellhas KP, Latchaw RE, Wendling LR, Gold LH. Vertebrobasilar injuries following cervical manipulation. JAMA. 1980;244(13):1450–3.

    Article  CAS  PubMed  Google Scholar 

  18. Weintraub MI. Beauty parlor stroke syndrome: report of five cases. JAMA. 1993;269(16):2085–6.

    Article  CAS  PubMed  Google Scholar 

  19. Wiebers DO, Mokri B. Internal carotid artery dissection after childbirth. Stroke. 1985;16(6):956–9.

    Article  CAS  PubMed  Google Scholar 

  20. Rubinstein SM, Peerdeman SM, van Tulder MW, Riphagen I, Haldeman S. A systematic review of the risk factors for cervical artery dissection. Stroke. 2005;36(7):1575–80.

    Article  PubMed  Google Scholar 

  21. Schievink WI, Bjornsson J, Piepgras DG. Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marfan’s syndrome and bilateral carotid artery dissections. Stroke. 1994;25(12):2492–6.

    Article  CAS  PubMed  Google Scholar 

  22. Vila N, Millan M, Ferrer X, Riutort N, Escudero D. Levels of alpha1-antitrypsin in plasma and risk of spontaneous cervical artery dissections: a case-control study. Stroke. 2003;34(9):E168–9.

    Article  CAS  PubMed  Google Scholar 

  23. Schievink WI, Michels VV, Piepgras DG. Neurovascular manifestations of heritable connective tissue disorders. A review. Stroke. 1994;25(4):889–903.

    Article  CAS  PubMed  Google Scholar 

  24. Hademenos GJ, Alberts MJ, Awad I, Mayberg M, Shepard T, Jagoda A, et al. Advances in the genetics of cerebrovascular disease and stroke. Neurology. 2001;56(8):997–1008.

    Article  CAS  PubMed  Google Scholar 

  25. Volker W, Ringelstein EB, Dittrich R, Maintz D, Nassenstein I, Heindel W, et al. Morphometric analysis of collagen fibrils in skin of patients with spontaneous cervical artery dissection. J Neurol Neurosurg Psychiatry. 2008;79(9):1007–12.

    Article  CAS  PubMed  Google Scholar 

  26. Schievink WI, Wijdicks EF, Michels VV, Vockley J, Godfrey M. Heritable connective tissue disorders in cervical artery dissections: a prospective study. Neurology. 1998;50(4):1166–9.

    Article  CAS  PubMed  Google Scholar 

  27. Brandt T, Morcher M, Hausser I. Association of cervical artery dissection with connective tissue abnormalities in skin and arteries. Front Neurol Neurosci. 2005;20:16–29.

    Article  CAS  PubMed  Google Scholar 

  28. Guillon B, Berthet K, Benslamia L, Bertrand M, Bousser MG, Tzourio C. Infection and the risk of spontaneous cervical artery dissection: a case-control study. Stroke. 2003;34(7):e79–81.

    Article  PubMed  Google Scholar 

  29. Pezzini A, Del ZE, Archetti S, Negrini R, Bani P, Albertini A, et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke. 2002;33(3):664–9.

    Article  CAS  PubMed  Google Scholar 

  30. Pezzini A, Caso V, Zanferrari C, Del ZE, Paciaroni M, Bertolino C, et al. Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case-control study. J Neurol Neurosurg Psychiatry. 2006;77(1):95–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Tzourio C, Benslamia L, Guillon B, Aidi S, Bertrand M, Berthet K, et al. Migraine and the risk of cervical artery dissection: a case-control study. Neurology. 2002;59(3):435–7.

    Article  CAS  PubMed  Google Scholar 

  32. Pezzini A, Granella F, Grassi M, Bertolino C, Del ZE, Immovilli P, et al. History of migraine and the risk of spontaneous cervical artery dissection. Cephalalgia. 2005;25(8):575–80.

    Article  CAS  PubMed  Google Scholar 

  33. Mokri B, Sundt Jr TM, Houser OW. Spontaneous internal carotid dissection, hemicrania, and Horner’s syndrome. Arch Neurol. 1979;36(11):677–80.

    Article  CAS  PubMed  Google Scholar 

  34. Mokri B, Silbert PL, Schievink WI, Piepgras DG. Cranial nerve palsy in spontaneous dissection of the extracranial internal carotid artery. Neurology. 1996;46(2):356–9.

    Article  CAS  PubMed  Google Scholar 

  35. Lichy C, Metso A, Pezzini A, Leys D, Metso T, Lyrer P, et al. Predictors of delayed stroke in patients with cervical artery dissection. Int J Stroke. 2012;11:10–4949.

    Google Scholar 

  36. Pelkonen O, Tikkakoski T, Pyhtinen J, Sotaniemi K. Cerebral CT and MRI findings in cervicocephalic artery dissection. Acta Radiol. 2004;45(3):259–65.

    Article  CAS  PubMed  Google Scholar 

  37. Menon R, Kerry S, Norris JW, Markus HS. Treatment of cervical artery dissection: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2008;79(10):1122–7.

    Article  CAS  PubMed  Google Scholar 

  38. Lyrer P, Engelter S. Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev 2003;(3):CD000255.

    Google Scholar 

  39. Kennedy F, Lanfranconi S, Hicks C, Reid J, Gompertz P, Price C, et al. Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis. Neurology. 2012;79(7):686–9.

    Article  CAS  PubMed  Google Scholar 

  40. Antiplatelet therapy vs. anticoagulation in cervical artery dissection: rationale and design of the Cervical Artery Dissection in Stroke Study (CADISS). Int J Stroke 2007;2(4):292–6.

    Google Scholar 

  41. Metso TM, Metso AJ, Helenius J, Haapaniemi E, Salonen O, Porras M, et al. Prognosis and safety of anticoagulation in intracranial artery dissections in adults. Stroke. 2007;38(6):1837–42.

    Article  CAS  PubMed  Google Scholar 

  42. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(1):227–76.

    Article  PubMed  Google Scholar 

  43. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–236.

    Article  PubMed  Google Scholar 

  44. Derex L, Nighoghossian N, Turjman F, Hermier M, Honnorat J, Neuschwander P, et al. Intravenous tPA in acute ischemic stroke related to internal carotid artery dissection. Neurology. 2000;54(11):2159–61.

    Article  CAS  PubMed  Google Scholar 

  45. Georgiadis D, Lanczik O, Schwab S, Engelter S, Sztajzel R, Arnold M, et al. IV thrombolysis in patients with acute stroke due to spontaneous carotid dissection. Neurology. 2005;64(9):1612–4.

    Article  CAS  PubMed  Google Scholar 

  46. Engelter ST, Dallongeville J, Kloss M, Metso TM, Leys D, Brandt T, et al. Thrombolysis in cervical artery dissection – data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database. Eur J Neurol. 2012;19(9):1199–206.

    Article  CAS  PubMed  Google Scholar 

  47. Georgiadis D, Arnold M, von Buedingen HC, Valko P, Sarikaya H, Rousson V, et al. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients. Neurology. 2009;72(21):1810–5.

    Article  CAS  PubMed  Google Scholar 

  48. DeOcampo J, Brillman J, Levy DI. Stenting: a new approach to carotid dissection. J Neuroimaging. 1997;7(3):187–90.

    CAS  PubMed  Google Scholar 

  49. Finsterer J, Strassegger J, Haymerle A, Hagmuller G. Bilateral stenting of symptomatic and asymptomatic internal carotid artery stenosis due to fibromuscular dysplasia. J Neurol Neurosurg Psychiatry. 2000;69(5):683–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Edwards NM, Fabian TC, Claridge JA, Timmons SD, Fischer PE, Croce MA. Antithrombotic therapy and endovascular stents are effective treatment for blunt carotid injuries: results from longterm followup. J Am Coll Surg. 2007;204(5):1007–13.

    Article  PubMed  Google Scholar 

  51. Chiche L, Praquin B, Koskas F, Kieffer E. Spontaneous dissection of the extracranial vertebral artery: indications and long-term outcome of surgical treatment. Ann Vasc Surg. 2005;19(1):5–10.

    Article  PubMed  Google Scholar 

  52. Engelter ST, Lyrer PA, Kirsch EC, Steck AJ. Long-term follow-up after extracranial internal carotid artery dissection. Eur Neurol. 2000;44(4):199–204.

    Article  CAS  PubMed  Google Scholar 

  53. Touze E, Gauvrit JY, Moulin T, Meder JF, Bracard S, Mas JL. Risk of stroke and recurrent dissection after a cervical artery dissection: a multicenter study. Neurology. 2003;61(10):1347–51.

    Article  CAS  PubMed  Google Scholar 

  54. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350(18):1862–71.

    Article  CAS  PubMed  Google Scholar 

  55. Bigazzi R, Bianchi S, Quilici N, Salvadori R, Baldari G. Bilateral fibromuscular dysplasia in identical twins. Am J Kidney Dis. 1998;32(6):E4.

    Article  CAS  PubMed  Google Scholar 

  56. Halpern MM, Sanford HS, Viamonte Jr M. Renal-artery abnormalities in three hypertensive sisters. Probable familial fibromuscular hyperplasia. JAMA. 1965;194(5):512–3.

    Article  CAS  PubMed  Google Scholar 

  57. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med. 1980;140(2):233–6.

    Article  CAS  PubMed  Google Scholar 

  58. Olin JW, Gornik HL, Bacharach JM, Biller J, Fine LJ, Gray BH, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the american heart association. Circulation. 2014;129(9):1048–78.

    Article  PubMed  Google Scholar 

  59. Cloft HJ, Kallmes DF, Kallmes MH, Goldstein JH, Jensen ME, Dion JE. Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg. 1998;88(3):436–40.

    Article  CAS  PubMed  Google Scholar 

  60. Hudgins LB, Limbacher JP. Fibromuscular dysplasia in Alport’s syndrome. J Tenn Med Assoc. 1982;75(11):733–5.

    CAS  PubMed  Google Scholar 

  61. Schievink WI, Limburg M. Angiographic abnormalities mimicking fibromuscular dysplasia in a patient with Ehlers-Danlos syndrome, type IV. Neurosurgery. 1989;25(3):482–3.

    Article  CAS  PubMed  Google Scholar 

  62. Persu A, Touze E, Mousseaux E, Barral X, Joffre F, Plouin PF. Diagnosis and management of fibromuscular dysplasia: an expert consensus. Eur J Clin Invest. 2012;42(3):338–47.

    Article  PubMed  Google Scholar 

  63. Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288–99.

    Article  CAS  PubMed  Google Scholar 

  64. Suzuki J, Kodama N. Moyamoya disease – a review. Stroke. 1983;14(1):104–9.

    Article  CAS  PubMed  Google Scholar 

  65. Yamashiro Y, Takahashi H, Takahashi K. Cerebrovascular Moyamoya disease. Eur J Pediatr. 1984;142(1):44–50.

    Article  CAS  PubMed  Google Scholar 

  66. Yilmaz EY, Pritz MB, Bruno A, Lopez-Yunez A, Biller J. Moyamoya: Indiana University Medical Center experience. Arch Neurol. 2001;58(8):1274–8.

    Article  CAS  PubMed  Google Scholar 

  67. Lin R, Xie Z, Zhang J, Xu H, Su H, Tan X, et al. Clinical and immunopathological features of Moyamoya disease. PLoS One. 2012;7(4):e36386.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  68. Weinberg DG, Arnaout OM, Rahme RJ, Aoun SG, Batjer HH, Bendok BR. Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg Focus. 2011;30(6):E20.

    Article  PubMed  Google Scholar 

  69. Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31(4):930–5.

    Article  CAS  PubMed  Google Scholar 

  70. Kaneko Y, Imamoto N, Mannoji H, Fukui M. Familial occurrence of moyamoya disease in the mother and four daughters including identical twins. Neurol Med Chir (Tokyo). 1998;38(6):349–54.

    Article  CAS  Google Scholar 

  71. Kang HS, Kim SK, Cho BK, Kim YY, Hwang YS, Wang KC. Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery. 2006;58(6):1074–80.

    Article  PubMed  Google Scholar 

  72. Mineharu Y, Takenaka K, Yamakawa H, Inoue K, Ikeda H, Kikuta KI, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. 2006;77(9):1025–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  73. Nanba R, Kuroda S, Tada M, Ishikawa T, Houkin K, Iwasaki Y. Clinical features of familial moyamoya disease. Childs Nerv Syst. 2006;22(3):258–62.

    Article  PubMed  Google Scholar 

  74. Shetty-Alva N, Alva S. Familial moyamoya disease in Caucasians. Pediatr Neurol. 2000;23(5):445–7.

    Article  CAS  PubMed  Google Scholar 

  75. Zafeiriou DI, Ikeda H, Anastasiou A, Vargiami E, Vougiouklis N, Katzos G, et al. Familial moyamoya disease in a Greek family. Brain Dev. 2003;25(4):288–90.

    Article  PubMed  Google Scholar 

  76. Linfante I, Ciarmiello A, Fusco C, Ronga B, Andreone V. Similar TIAs and corresponding alterations in regional cerebral perfusion in Caucasian monozygotic twins with moyamoya disease. Clin Imaging. 2002;26(6):378–81.

    Article  PubMed  Google Scholar 

  77. Andreone V, Ciarmiello A, Fusco C, Ambrosanio G, Florio C, Linfante I. Moyamoya disease in Italian monozygotic twins. Neurology. 1999;53(6):1332–5.

    Article  CAS  PubMed  Google Scholar 

  78. Han DH, Nam DH, Oh CW. Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis. Clin Neurol Neurosurg. 1997;99 Suppl 2:S151–5.

    Article  PubMed  Google Scholar 

  79. Serdaru M, Gray F, Merland JJ, Escourolle R, Grumbach R. Moyamoya disease and intracerebral hematoma. Clinical pathological report. Neuroradiology. 1979;18(1):47–52.

    Article  CAS  PubMed  Google Scholar 

  80. Rao M, Zhang H, Liu Q, Zhang S, Hu L, Deng F. Clinical and experimental pathology of Moyamoya disease. Chin Med J (Engl). 2003;116(12):1845–9.

    Google Scholar 

  81. Oppenheim JS, Gennuso R, Sacher M, Hollis P. Acute atraumatic subdural hematoma associated with moyamoya disease in an African-American. Neurosurgery. 1991;28(4):616–8.

    Article  CAS  PubMed  Google Scholar 

  82. Khan N, Schuknecht B, Boltshauser E, Capone A, Buck A, Imhof HG, et al. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures. Acta Neurochir (Wien). 2003;145(12):1061–71.

    Article  CAS  Google Scholar 

  83. Houkin K, Aoki T, Takahashi A, Abe H. Diagnosis of moyamoya disease with magnetic resonance angiography. Stroke. 1994;25(11):2159–64.

    Article  CAS  PubMed  Google Scholar 

  84. Tsuchiya K, Makita K, Furui S. Moyamoya disease: diagnosis with three-dimensional CT angiography. Neuroradiology. 1994;36(6):432–4.

    Article  CAS  PubMed  Google Scholar 

  85. Yamada I, Nakagawa T, Matsushima Y, Shibuya H. High-resolution turbo magnetic resonance angiography for diagnosis of Moyamoya disease. Stroke. 2001;32(8):1825–31.

    Article  CAS  PubMed  Google Scholar 

  86. Yamada I, Matsushima Y, Suzuki S. Moyamoya disease: diagnosis with three-dimensional time-of-flight MR angiography. Radiology. 1992;184(3):773–8.

    Article  CAS  PubMed  Google Scholar 

  87. Smith ER, Scott RM. Surgical management of moyamoya syndrome. Skull Base. 2005;15(1):15–26.

    Article  PubMed Central  PubMed  Google Scholar 

  88. Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery. 2004;54(4):840–4.

    Article  PubMed  Google Scholar 

  89. Matsushima T, Inoue TK, Suzuki SO, Inoue T, Ikezaki K, Fukui M, et al. Surgical techniques and the results of a fronto-temporo-parietal combined indirect bypass procedure for children with moyamoya disease: a comparison with the results of encephalo-duro-arterio-synangiosis alone. Clin Neurol Neurosurg. 1997;99 Suppl 2:S123–7.

    Article  PubMed  Google Scholar 

  90. Isono M, Ishii K, Kamida T, Inoue R, Fujiki M, Kobayashi H. Long-term outcomes of pediatric moyamoya disease treated by encephalo-duro-arterio-synangiosis. Pediatr Neurosurg. 2002;36(1):14–21.

    Article  PubMed  Google Scholar 

  91. Touho H. A simple surgical technique of direct anastomosis for treatment of moyamoya disease: technical note. Surg Neurol. 2004;62(4):366–8.

    Article  PubMed  Google Scholar 

  92. Kim DS, Kang SG, Yoo DS, Huh PW, Cho KS, Park CK. Surgical results in pediatric moyamoya disease: angiographic revascularization and the clinical results. Clin Neurol Neurosurg. 2007;109(2):125–31.

    Article  PubMed  Google Scholar 

  93. Houkin K, Kuroda S, Nakayama N. Cerebral revascularization for moyamoya disease in children. Neurosurg Clin N Am. 2001;12(3):575–84. ix.

    CAS  PubMed  Google Scholar 

  94. Dauser RC, Tuite GF, McCluggage CW. Dural inversion procedure for moyamoya disease. Technical note. J Neurosurg. 1997;86(4):719–23.

    Article  CAS  PubMed  Google Scholar 

  95. Woitzik J, Horn P, Vajkoczy P, Schmiedek P. Intraoperative control of extracranial-intracranial bypass patency by near-infrared indocyanine green videoangiography. J Neurosurg. 2005;102(4):692–8.

    Article  PubMed  Google Scholar 

  96. Grenier Y, Tomita T, Marymont MH, Byrd S, Burrowes DM. Late postirradiation occlusive vasculopathy in childhood medulloblastoma. Report of two cases. J Neurosurg. 1998;89(3):460–4.

    Article  CAS  PubMed  Google Scholar 

  97. Ferroir JP, Marro B, Belkacemi Y, Stilhart B, Schlienger M. Cerebral infarction related to intracranial radiation arteritis twenty-four years after encephalic radiation therapy. Rev Neurol (Paris). 2007;163(1):96–8.

    Article  CAS  Google Scholar 

  98. Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy. Stroke. 1995;26(1):131–6.

    Article  CAS  PubMed  Google Scholar 

  99. Aoki S, Hayashi N, Abe O, Shirouzu I, Ishigame K, Okubo T, et al. Radiation-induced arteritis: thickened wall with prominent enhancement on cranial MR images report of five cases and comparison with 18 cases of Moyamoya disease. Radiology. 2002;223(3):683–8.

    Article  PubMed  Google Scholar 

  100. Ishikawa N, Tajima G, Yofune N, Nishimura S, Kobayashi M. Moyamoya syndrome after cranial irradiation for bone marrow transplantation in a patient with acute leukemia. Neuropediatrics. 2006;37(6):364–6.

    Article  CAS  PubMed  Google Scholar 

  101. Omura M, Aida N, Sekido K, Kakehi M, Matsubara S. Large intracranial vessel occlusive vasculopathy after radiation therapy in children: clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 1997;38(2):241–9.

    Article  CAS  PubMed  Google Scholar 

  102. Mueller S, Fullerton HJ, Stratton K, Leisenring W, Weathers RE, Stovall M, et al. Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys. 2013;86(4):649–55.

    Article  PubMed Central  PubMed  Google Scholar 

  103. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012;11(10):906–17.

    Article  PubMed  Google Scholar 

  104. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders. 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.

    Article  PubMed  Google Scholar 

  105. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130(Pt 12):3091–101.

    Article  PubMed  Google Scholar 

  106. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007;146(1):34–44.

    Article  PubMed  Google Scholar 

  107. Ducros A, Bousser MG. Reversible cerebral vasoconstriction syndrome. Pract Neurol. 2009;9(5):256–67.

    Article  PubMed  Google Scholar 

  108. Whyte CA, Calabrese LH. Reversible cerebral vasoconstriction syndrome. Headache. 2009;49(4):597–8.

    Article  PubMed  Google Scholar 

  109. Moskowitz SI, Calabrese LH, Weil RJ. Benign angiopathy of the central nervous system presenting with intracerebral hemorrhage. Surg Neurol. 2007;67(5):522–7.

    Article  PubMed  Google Scholar 

  110. Ghosh PS, Rothner AD, Zahka KG, Friedman NR. Reversible cerebral vasoconstriction syndrome: a rare entity in children presenting with thunderclap headache. J Child Neurol. 2011;26(12):1580–4.

    Article  PubMed  Google Scholar 

  111. Bouchard M, Verreault S, Gariepy JL, Dupre N. Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome. Headache. 2009;49(1):142–5.

    Article  PubMed  Google Scholar 

  112. French KF, Hoesch RE, Allred J, Wilder M, Smith AG, Digre KB, et al. Repetitive use of intra-arterial verapamil in the treatment of reversible cerebral vasoconstriction syndrome. J Clin Neurosci. 2012;19(1):174–6.

    Article  PubMed  Google Scholar 

  113. Ioannidis I, Nasis N, Agianniotaki A, Katsouda E, Andreou A. Reversible cerebral vasoconstriction syndrome: treatment with multiple sessions of intra-arterial nimodipine and angioplasty. Interv Neuroradiol. 2012;18(3):297–302.

    CAS  PubMed Central  PubMed  Google Scholar 

  114. Farid H, Tatum JK, Wong C, Halbach VV, Hetts SW. Reversible cerebral vasoconstriction syndrome: treatment with combined intra-arterial verapamil infusion and intracranial angioplasty. AJNR Am J Neuroradiol. 2011;32(10):E184–7.

    Article  CAS  PubMed  Google Scholar 

  115. Braun KP, Bulder MM, Chabrier S, Kirkham FJ, Uiterwaal CS, Tardieu M, et al. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain. 2009;132(Pt 2):544–57.

    CAS  PubMed Central  PubMed  Google Scholar 

  116. Amlie-Lefond C, Bernard TJ, Sebire G, Friedman NR, Heyer GL, Lerner NB, et al. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation. 2009;119(10):1417–23.

    Article  PubMed Central  PubMed  Google Scholar 

  117. Sebire G. Transient cerebral arteriopathy in childhood. Lancet. 2006;368(9529):8–10.

    Article  PubMed  Google Scholar 

  118. Chabrier S, Rodesch G, Lasjaunias P, Tardieu M, Landrieu P, Sebire G. Transient cerebral arteriopathy: a disorder recognized by serial angiograms in children with stroke. J Child Neurol. 1998;13(1):27–32.

    Article  CAS  PubMed  Google Scholar 

  119. Bernard TJ, Manco-Johnson MJ, Lo W, MacKay MT, Ganesan V, DeVeber G, et al. Towards a consensus-based classification of childhood arterial ischemic stroke. Stroke. 2012;43(2):371–7.

    Article  PubMed Central  PubMed  Google Scholar 

  120. Yeon JY, Shin HJ, Seol HJ, Kim JS, Hong SC. Unilateral intracranial arteriopathy in pediatric stroke: course, outcome, and prediction of reversible arteriopathy. Stroke. 2014;45(4):1173–6.

    Article  PubMed  Google Scholar 

  121. Salvarani C, Brown Jr RD, Hunder GG. Adult primary central nervous system vasculitis. Lancet. 2012;380(9843):767–77.

    Article  PubMed  Google Scholar 

  122. Cravioto H, Feigin I. Noninfectious granulomatous angiitis with a predilection for the nervous system. Neurology. 1959;9:599–609.

    Article  CAS  PubMed  Google Scholar 

  123. Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore). 1988;67(1):20–39.

    Article  CAS  Google Scholar 

  124. Hajj-Ali RA, Calabrese LH. Primary angiitis of the central nervous system. Autoimmun Rev. 2013;12(4):463–6.

    Article  PubMed  Google Scholar 

  125. Calabrese L. Primary angiitis of the central nervous system: the penumbra of vasculitis. J Rheumatol. 2001;28(3):465–6.

    CAS  PubMed  Google Scholar 

  126. Calabrese LH. Diagnostic strategies in vasculitis affecting the central nervous system. Cleve Clin J Med. 2002;69 Suppl 2:SII105–8.

    PubMed  Google Scholar 

  127. Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, et al. Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain. 2005;128(Pt 3):500–15.

    Article  PubMed  Google Scholar 

  128. Danve A, Grafe M, Deodhar A. Amyloid beta-related angiitis - a case report and comprehensive review of literature of 94 cases. Semin Arthritis Rheum. 2014;14:10.

    Google Scholar 

  129. Salvarani C, Hunder GG, Morris JM, Brown Jr RD, Christianson T, Giannini C. Abeta-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology. 2013;81(18):1596–603.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  130. Bogner S, Bernreuther C, Matschke J, Barrera-Ocampo A, Sepulveda-Falla D, Leypoldt F, et al. Immune activation in amyloid-beta-related angiitis correlates with decreased parenchymal amyloid-beta plaque load. Neurodegener Dis. 2014;13(1):38–44.

    CAS  PubMed  Google Scholar 

  131. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology. 2007;68(17):1411–6.

    Article  CAS  PubMed  Google Scholar 

  132. Child ND, Braksick SA, Flanagan EP, Keegan BM, Giannini C, Kantarci OH. Amyloid-beta-related angiitis presenting as a uveomeningeal syndrome. Neurology. 2013;81(20):1796–8.

    Article  PubMed  Google Scholar 

  133. Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol. 2004;55(2):250–6.

    Article  PubMed  Google Scholar 

  134. Gonzalez-Gay MA, Martinez-Dubois C, Agudo M, Pompei O, Blanco R, Llorca J. Giant cell arteritis: epidemiology, diagnosis, and management. Curr Rheumatol Rep. 2010;12(6):436–42.

    Article  PubMed  Google Scholar 

  135. Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev. 2012;11(6-7):A544–54.

    Article  PubMed  Google Scholar 

  136. Fraser JA, Weyand CM, Newman NJ, Biousse V. The treatment of giant cell arteritis. Rev Neurol Dis. 2008;5(3):140–52.

    PubMed Central  PubMed  Google Scholar 

  137. Schmidt WA. Ultrasound in vasculitis. Clin Exp Rheumatol. 2014;32(1 Suppl 80):S71–7.

    PubMed  Google Scholar 

  138. Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002;46(5):1309–18.

    Article  CAS  PubMed  Google Scholar 

  139. Kohrman MH, Huttenlocher PR. Takayasu arteritis: a treatable cause of stroke in infancy. Pediatr Neurol. 1986;2(3):154–8.

    Article  CAS  PubMed  Google Scholar 

  140. Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu’s arteritis: a 2011 update. Autoimmun Rev. 2011;11(1):61–7.

    Article  CAS  PubMed  Google Scholar 

  141. Camara-Lemarroy CR, Lara-Campos JG, Perez-Contreras E, Rodriguez-Gutierrez R, Galarza-Delgado DA. Takayasu’s arteritis and posterior reversible encephalopathy syndrome: a case-based review. Clin Rheumatol. 2013;32(3):409–15.

    Article  PubMed  Google Scholar 

  142. Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol. 2005;17(1):16–24.

    Article  CAS  PubMed  Google Scholar 

  143. Bousser MG, Biousse V. Small vessel vasculopathies affecting the central nervous system. J Neuroophthalmol. 2004;24(1):56–61.

    Article  PubMed  Google Scholar 

  144. Benseler S, Schneider R. Central nervous system vasculitis in children. Curr Opin Rheumatol. 2004;16(1):43–50.

    Article  PubMed  Google Scholar 

  145. Fujiwara S, Yamano T, Hattori M, Fujiseki Y, Shimada M. Asymptomatic cerebral infarction in Kawasaki disease. Pediatr Neurol. 1992;8(3):235–6.

    Article  CAS  PubMed  Google Scholar 

  146. Lapointe JS, Nugent RA, Graeb DA, Robertson WD. Cerebral infarction and regression of widespread aneurysms in Kawasaki’s disease: case report. Pediatr Radiol. 1984;14(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  147. Suda K, Matsumura M, Ohta S. Kawasaki disease complicated by cerebral infarction. Cardiol Young. 2003;13(1):103–5.

    Article  PubMed  Google Scholar 

  148. Templeton PA, Dunne MG. Kawasaki syndrome: cerebral and cardiovascular complications. J Clin Ultrasound. 1987;15(7):483–5.

    Article  CAS  PubMed  Google Scholar 

  149. Laversuch CJ, Brown MM, Clifton A, Bourke BE. Cerebral venous thrombosis and acquired protein S deficiency: an uncommon cause of headache in systemic lupus erythematosus. Br J Rheumatol. 1995;34(6):572–5.

    Article  CAS  PubMed  Google Scholar 

  150. Freire BF, da Silva RC, Fabro AT, dos Santos DC. Is systemic lupus erythematosus a new risk factor for atherosclerosis? Arq Bras Cardiol. 2006;87(3):300–6.

    Article  PubMed  Google Scholar 

  151. Chartash EK, Lans DM, Paget SA, Qamar T, Lockshin MD. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med. 1989;86(4):407–12.

    Article  CAS  PubMed  Google Scholar 

  152. Fluture A, Chaudhari S, Frishman WH. Valvular heart disease and systemic lupus erythematosus: therapeutic implications. Heart Dis. 2003;5(5):349–53.

    Article  PubMed  Google Scholar 

  153. Gan J, Zheng HB, Xi J, Zhou D, Shang HF, Lai XH. A case of neuro-vasculo-Behcet disease. Eur J Neurol. 2007;14(7):e16–7.

    Article  CAS  PubMed  Google Scholar 

  154. Mohammed RH, Nasef A, Kewan HH, Al SM. Vascular neurobehcet disease: correlation with current disease activity forum and systemic vascular involvement. Clin Rheumatol. 2012;31(7):1033–40.

    Article  PubMed  Google Scholar 

  155. Corse AM, Stern BJ. Neurosarcoidosis and stroke. Stroke. 1990;21(1):152–3.

    CAS  PubMed  Google Scholar 

  156. Hodge MH, Williams RL, Fukui MB. Neurosarcoidosis presenting as acute infarction on diffusion-weighted MR imaging: summary of radiologic findings. AJNR Am J Neuroradiol. 2007;28(1):84–6.

    CAS  PubMed  Google Scholar 

  157. Peno IC, De las Heras Revilla V, Carbonell BP, Di Capua SD, Ferrer ME, Garcia-Cobos R, et al. Neurobehcet disease: clinical and demographic characteristics. Eur J Neurol. 2012;19(9):1224–7.

    Article  PubMed  Google Scholar 

  158. O’Dwyer JP, Al-Moyeed BA, Farrell MA, Pidgeon CN, Collins DR, Fahy A, et al. Neurosarcoidosis-related intracranial haemorrhage: three new cases and a systematic review of the literature. Eur J Neurol. 2013;20(1):71–8.

    Article  PubMed  Google Scholar 

  159. Fernandez-Perez ER, Grabscheid E, Scheinfeld NS. A case of systemic malignant atrophic papulosis (Kohlmeier-Degos’ disease). J Natl Med Assoc. 2005;97(3):421–5.

    PubMed Central  PubMed  Google Scholar 

  160. Scheinfeld N. Malignant atrophic papulosis. Clin Exp Dermatol. 2007;32(5):483–7.

    Article  CAS  PubMed  Google Scholar 

  161. Sokol DK, McIntyre JA, Short RA, Gutt J, Wagenknecht DR, Biller J, et al. Henoch-Schonlein purpura and stroke: antiphosphatidylethanolamine antibody in CSF and serum. Neurology. 2000;55(9):1379–81.

    Article  CAS  PubMed  Google Scholar 

  162. Macdonald DR. Neurologic complications of chemotherapy. Neurol Clin. 1991;9(4):955–67.

    CAS  PubMed  Google Scholar 

  163. Igarashi M, Gilmartin RC, Gerald B, Wilburn F, Jabbour JT. Cerebral arteritis and bacterial meningitis. Arch Neurol. 1984;41(5):531–5.

    Article  CAS  PubMed  Google Scholar 

  164. Reddy AT, Witek K. Neurologic complications of chemotherapy for children with cancer. Curr Neurol Neurosci Rep. 2003;3(2):137–42.

    Article  PubMed  Google Scholar 

  165. Armstrong T, Gilbert MR. Central nervous system toxicity from cancer treatment. Curr Oncol Rep. 2004;6(1):11–9.

    Article  PubMed  Google Scholar 

  166. Schiff D, Wen P. Central nervous system toxicity from cancer therapies. Hematol Oncol Clin North Am. 2006;20(6):1377–98.

    Article  PubMed  Google Scholar 

  167. Atalaia A, Ferro J, Antunes F. Stroke in an HIV-infected patient. J Neurol. 1992;239(6):356–7.

    Article  CAS  PubMed  Google Scholar 

  168. Menge T, Neumann-Haefelin T, von Giesen HJ, Arendt G. Progressive stroke in an HIV-1-positive patient under protease inhibitors. Eur Neurol. 2000;44(4):252–4.

    Article  CAS  PubMed  Google Scholar 

  169. Ortiz G, Koch S, Romano JG, Forteza AM, Rabinstein AA. Mechanisms of ischemic stroke in HIV-infected patients. Neurology. 2007;68(16):1257–61.

    Article  CAS  PubMed  Google Scholar 

  170. Poltera AA. Thrombogenic intracranial vasculitis in tuberculous meningitis. A 20 year “post mortem” survey. Acta Neurol Belg. 1977;77(1):12–24.

    CAS  PubMed  Google Scholar 

  171. Leiguarda R, Berthier M, Starkstein S, Nogues M, Lylyk P. Ischemic infarction in 25 children with tuberculous meningitis. Stroke. 1988;19(2):200–4.

    Article  CAS  PubMed  Google Scholar 

  172. de Carvalho CA, Allen JN, Zafranis A, Yates AJ. Coccidioidal meningitis complicated by cerebral arteritis and infarction. Hum Pathol. 1980;11(3):293–6.

    Article  PubMed  Google Scholar 

  173. Bonawitz C, Castillo M, Mukherji SK. Comparison of CT and MR features with clinical outcome in patients with Rocky Mountain spotted fever. AJNR Am J Neuroradiol. 1997;18(3):459–64.

    CAS  PubMed  Google Scholar 

  174. Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182–90.

    Article  PubMed  Google Scholar 

  175. Iqbal S. A comprehensive study of the anatomical variations of the circle of Willis in adult human brains. J Clin Diagn Res. 2013;7(11):2423–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  176. Alpers BJ, Berry RG, Paddison RM. Anatomical studies of the circle of Willis in normal brain. AMA Arch Neurol Psychiatry. 1959;81(4):409–18.

    Article  CAS  PubMed  Google Scholar 

  177. Verbiest H. Radiological findings in a case with absence of the left internal carotid artery and compression of several cranial nerve roots in the posterior fossa by the basilar artery. Med Contemp. 1954;72(12):601–9.

    CAS  PubMed  Google Scholar 

  178. Yoon SM, Chun YI, Kwon Y, Kwun BD. Vertebrobasilar junction aneurysms associated with fenestration: experience of five cases treated with Guglielmi detachable coils. Surg Neurol. 2004;61(3):248–54.

    Article  PubMed  Google Scholar 

  179. Kloska SP, Schlegel PM, Strater R, Niederstadt TU. Causality of pediatric brainstem infarction and basilar artery fenestration? Pediatr Neurol. 2006;35(6):436–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The author would like to thank Vimal Patel, PhD, medical and scientific writer at NorthShore Neurological Institute for assistance with preparing figures and copy-editing of the text.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rima M. Dafer M.D., M.P.H. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Dafer, R.M. (2016). Secondary Prevention After Non-atherosclerotic Cerebral Vasculopathies. In: Ovbiagele, B. (eds) Ischemic Stroke Therapeutics. Springer, Cham. https://doi.org/10.1007/978-3-319-17750-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17750-2_16

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17749-6

  • Online ISBN: 978-3-319-17750-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics